HD-OPM Archive
Topics › Supplements & vitamins

COSMOS multivitamin matches Centrum-type RDA doses except B12 at 10x the RDA

Louis Nervegna · Nov 15, 2026 · ♥ 7 reactions · 8 comments · original Facebook post
Supplements & vitaminsBrain health & dementiaAging & longevity
AI summary & key facts

Louis shows the ingredient list of the multivitamin used in the COSMOS trial next to the one used in Physicians' Health Study II. Nearly all nutrients are near RDA levels, but B12 is about 10x the RDA, and he suspects that dose may have driven the cognitive benefit seen in COSMOS. COSMOS showed slower cognitive decline in older adults, and PHS II showed an 8% cancer reduction.

These were the exact ingredients in the multivitamin used in the Harvard COSMOS trial at MGH/Brigham hospital in Boston.

This is from the supplementary material in the journal publication on the trial: Effect of multivitamin-mineral supplementation versus placebo on cognitive function:… (The American Journal of Clinical Nutrition, 2024).

The COSMOS trial demonstrated a slowing of cognitive decline and memory loss in older people, and an overall reduction in cognitive aging: ↪ Daily multivitamin slowed cognitive aging by about two years in a COSMOS meta-analysis.

You can read past posts about this trial by searching the group for the tag #cosmosHD.

The first column shows the multivitamin used in COSMOS.

The second column shows the multivitamin used in the Physician’s Health Study II randomized trial, which demonstrated an 8% reduction in cancer rates compared to placebo: ↪ Physicians' Health Study II: a basic multivitamin cut total cancer 8% over 14 years.

All the ingredients are close to the RDA, except B12 which is 10x the RDA. Given the known neurological benefits of B12, it is hard not to suspect that the 10x RDA dose played an outsized role in the results: ↪ Even 'normal' vitamin B12 may be too low for older brains; active B12 tied to lesions.

#cosmosHD #multivitaminHD #vitaminb12HD #brainHD #memoryHD #agingHD #longevityHD

Research cited

← newer: STREAM: why 'noninferior' does not make stopping statins at older: GLUT4 is the key glucose transporter for insulin resistance →